Oral semaglutide: an OASIS from injectables

P Manjoo, AM Sharma - The Lancet, 2023 - thelancet.com
The OASIS 1 trial by Filip K Knop and colleagues1 demonstrates the greatest magnitude of
weight loss to date among oral anti-obesity medications. 2− 4 In this randomised, double …
被引用次数：1 相关文章

[引用][C] Oral semaglutide: an OASIS from injectables

P Manjoo, AM Sharma - Lancet (London, England), 2023 - pubmed.ncbi.nlm.nih.gov

[引用][C] Oral semaglutide: an OASIS from injectables.

P Manjoo, AM Sharma - Lancet (London, England), 2023 - europepmc.org
Oral semaglutide: an OASIS from injectables. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …